(Q40586154)

21 September 2017

Current status and future of relapsed primary central nervous system lymphoma (PCNSL). (English)

1 reference

central nervous system lymphoma

21 September 2017

1 reference

based on heuristic

inferred from title

primary central nervous system lymphoma

1 reference

Rose Marie Tyson

1

1 reference

21 September 2017

Tali Siegal

2

1 reference

21 September 2017

Nancy D Doolittle

3

1 reference

21 September 2017

Cynthia Lacy

4

1 reference

21 September 2017

Dale F Kraemer

5

1 reference

21 September 2017

Edward A Neutwelt

6

1 reference

21 September 2017

1 April 2003

1 reference

21 September 2017

1 reference

21 September 2017

44

1 reference

21 September 2017

4

1 reference

21 September 2017

627-633

1 reference

Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy

21 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000055057

10.1080/1042819021000055057

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference